PubMed COVID-19 Clinical Care
40911 - 40920 of 44979 results found
Comparison of coagulation profile and thromboembolic events among patients undergoing spinal surgery before and after COVID-19 pandemic
Description
CONCLUSION: The rate of thromboembolic events seems to be increased during the COVID-19 pandemic. These findings urge more stringent monitoring of the patients' coagulation parameters during the COVID-19 outbreak.
SARS-CoV-2 infection complicated by neuro- or psycho-COVID
Description
No abstract
Perceived stress, stress coping strategies, and post-traumatic-growth among healthcare professionals during COVID-19 pandemic
Description
AIM: The purpose of this research was to identify the perceived stress coping strategies, and Post-Traumatic-Growth (PTG) among Iranian healthcare professionals.
Differential Risk of SARS-CoV-2 Infection by Occupation: Evidence from the Virus Watch prospective cohort study in England and Wales
Description
CONCLUSIONS: Occupational differences in SARS-CoV-2 infection risk vary over time and are robust to adjustment for socio-demographic, health-related, and non-workplace activity-related potential confounders. Direct investigation into workplace
Interventions to improve well-being among children and youth aged 6-17 years during the COVID-19 pandemic: a systematic review
Description
CONCLUSIONS: Studies deploying synchronous interventions most often reported improved well-being among children and youth largely in the domain of health and nutrition, specifically physical and mental health. Targeted approaches will be crucial to
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
Description
CONCLUSION: This study showed a very high prevalence with approximately 2/3 of Togolese street adolescents having antibodies to SARS-CoV-2 due to a previous infection. These results confirm an under-reporting of COVID-19 cases in Togo, questioning
Biological composition, efficacy and primary efficacy endpoint of SARS-CoV-2 vaccines: A special communication
Description
Severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, China, in late December 2019 and rapidly spread out globally, affecting 130 million individuals and starting a global pandemic. An efficacious vaccine is considered an
